Moderna (MRNA)
Commercializes mRNA respiratory vaccines while developing oncology and rare-disease therapies.
$171.46
vs last close−1.48 (−0.86%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$1.31
Revenue estimate
$895.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported−$2.50−$2.52−$2.13−$0.51−$2.11−$3.40−$1.97Pending
Estimate−$2.68−$2.92−$2.99−$1.87−$2.54−$4.45−$2.03−$1.31
Surprise+6.7%+13.7%+28.8%+72.7%+16.9%+23.6%+3.0%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Jul '26Nov '26
Reported$956.0M$107.0M$142.0M$1.02B$678.0M$389.0M$145.0MPending
Estimate$942.8M$116.7M$893.3M$920.9M$635.2M$236.4M$102.9M$895.0M
Surprise+1.4%−8.3%−84.1%+10.3%+6.7%+64.6%+40.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.77 | — | — |
| Sep 2027 | −$0.58 | — | — |
| Jun 2027 | −$1.93 | — | — |
| Mar 2027 | −$1.69 | — | — |
| Dec 2026 | −$1.69 | — | — |
| Nov 2026 | −$1.31 | — | — |
| Jul 2026 | −$2.03 | −$1.97 | +3.0% |
| May 2026 | −$4.45 | −$3.40 | +23.6% |
| Feb 2026 | −$2.54 | −$2.11 | +16.9% |
| Nov 2025 | −$1.87 | −$0.51 | +72.7% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Oct 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Sep 2018 | |||
| Dec 2018 | |||
| Mar 2018 | |||
| Dec 2017 | |||
| Sep 2017 | |||
| Jun 2017 | |||
| Mar 2017 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.77 | — | — | $984.8M | — | — | — |
| Sep 2027 | −$0.58 | — | — | $1.10B | — | — | — |
| Jun 2027 | −$1.93 | — | — | $120.4M | — | — | — |
| Mar 2027 | −$1.69 | — | — | $264.3M | — | — | — |
| Dec 2026 | −$1.69 | — | — | $667.8M | — | — | — |
| Nov 5, 2026 | −$1.31 | — | — | $895.0M | — | — | — |
| Jul 31, 2026 | −$2.03 | −$1.97 | +3.0% | $102.9M | $145.0M | +40.9% | −5.4% |
| May 1, 2026 | −$4.45 | −$3.40 | +23.6% | $236.4M | $389.0M | +64.6% | −1.2% |
| Feb 13, 2026 | −$2.54 | −$2.11 | +16.9% | $635.2M | $678.0M | +6.7% | +5.3% |
| Nov 6, 2025 | −$1.87 | −$0.51 | +72.7% | $920.9M | $1.02B | +10.3% | +3.3% |
| Aug 1, 2025 | |||||||
| May 1, 2025 | |||||||
| Feb 14, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 1, 2024 | |||||||
| May 2, 2024 | |||||||
| Feb 22, 2024 | |||||||
| Nov 2, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 4, 2023 | |||||||
| Feb 23, 2023 | |||||||
| Nov 3, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Oct 29, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 6, 2019 | |||||||
| Sep 30, 2018 | |||||||
| Dec 7, 2018 | |||||||
| Mar 31, 2018 | |||||||
| Dec 31, 2017 | |||||||
| Sep 30, 2017 | |||||||
| Jun 30, 2017 | |||||||
| Mar 31, 2017 |